Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Bought 25,000 @0.19

<< Previous

Bullboard Posts

Next >>

Comment by DeathXray33on Nov 04, 2023 12:41am

143 Views

Post# 35717058

RE:Bought 25,000 @0.19

james700 wrote: Until this gets approval or a JV, the stock will remain low. However, the science appears to be better than Keytruda, which is already approved, so let's hope the results lead to a good 2024... Cash burn will be key, as the cost of capital has increased with the higher interest rates. Here we go.

Hi, I picked up over 5k yesterday also... Thank you...

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant